Crescita Therapeutics Investor Relations Material
Latest events
Q4 2024
17 Mar, 2025
Q3 2024
5 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Crescita Therapeutics Inc
Access all reports
Crescita Therapeutics Inc. is a Canadian company engaged in the commercial dermatology sector. It specializes in both prescription and non-prescription skincare products aimed at treating various skin conditions and diseases. Crescita's product portfolio includes a notable prescription product, Pliaglis, which utilizes a proprietary phase-changing cream technology and is available in over 40 countries. The company is headquartered in Laval, Quebec, and its shares are listed on the Toronto Stock Exchange.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
CTX
Country
🇨🇦 Canada